12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-05-11), Tyme Technologies's 12-1 Month Momentum % is -66.35%.
The industry rank for Tyme Technologies's 12-1 Month Momentum % or its related term are showing as below:
TYME's 12-1 Month Momentum % is not ranked
in the Biotechnology industry.
Industry Median: -22.355
vs TYME: -66.35
Competitive Comparison of Tyme Technologies's 12-1 Month Momentum %
For the Biotechnology subindustry, Tyme Technologies's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tyme Technologies's 12-1 Month Momentum % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Tyme Technologies's 12-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Tyme Technologies's 12-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Tyme Technologies 12-1 Month Momentum % Related Terms
Thank you for viewing the detailed overview of Tyme Technologies's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.
Tyme Technologies (Tyme Technologies) Business Description
Tyme Technologies Inc is the U.S based clinical-stage biotechnology company. The company is focused on the development and commercialization of targeted cancer therapeutics with a broad range of oncology indications for humans. SM 88, its proprietary drug candidate compound, is a novel compound that has the potential to alter defenses to oxidative stress and increase free radical availability to the cancer cell. The company is currently conducting a Phase II trial in prostate cancer.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TYME has been successfully added to your